Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distraction adds to the cognitive burden in multiple sclerosis.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Update on biomarkers in neuromyelitis optica.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Cannabinoid pharmacology: the first 66 years.
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
The benefits of exercise training in multiple sclerosis.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Plasma chemerin levels in patients with multiple sclerosis.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
RNF and Betaseron® Tolerability Study (REFORMS)
Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Pages